Chloprime 100 T Tablet contains Chlorpromazine 100 mg and Trihexyphenidyl 2 mg, a combination formulation used in the treatment and management of various psychiatric disorders under medical supervision. The medicine combines the therapeutic benefits of an antipsychotic agent with an anticholinergic component to provide comprehensive symptom management while helping improve treatment tolerability. This combination is widely utilized in psychiatric practice where long-term management and patient comfort are important considerations.

Chlorpromazine works by modulating dopamine activity within the brain, helping control symptoms such as hallucinations, delusions, agitation, disturbed thinking, and behavioral abnormalities associated with psychotic disorders. Trihexyphenidyl is included to help reduce extrapyramidal symptoms such as rigidity, tremors, muscle stiffness, and involuntary movements that may occur during antipsychotic treatment. Together, these ingredients help optimize therapeutic outcomes while minimizing certain treatment-related complications.

The tablet is commonly prescribed for schizophrenia, psychotic disorders, severe behavioral disturbances, and other psychiatric conditions as determined by a healthcare professional. Regular treatment may help improve emotional stability, reduce psychotic symptoms, and enhance overall patient functioning. The dosage and duration of therapy should be carefully individualized according to the patient's condition, treatment response, and ongoing clinical evaluation.

With the increasing focus on mental healthcare and the growing demand for effective psychiatric treatment options, Chloprime 100 T Tablet maintains strong relevance in the neuropsychiatry segment. Its established clinical utility, physician confidence, and importance in managing complex psychiatric disorders contribute to sustained market demand. The product offers valuable business opportunities and long-term growth potential for retailers and distributors operating within the psychiatric pharmaceutical sector.

Chloprime 100 T Tablet may cause drowsiness, dizziness, dry mouth, constipation, blurred vision, low blood pressure, weight changes, tremors, restlessness, or difficulty concentrating. Some individuals may experience movement disorders, mood alterations, or other serious adverse effects requiring medical attention.

Chloprime 100 T Tablet is indicated for schizophrenia, psychotic disorders, severe behavioral disturbances, and other psychiatric conditions as advised by a healthcare professional. It also helps manage extrapyramidal symptoms associated with antipsychotic therapy.

This medication should be used only under the supervision of a qualified healthcare professional. Patients should avoid alcohol and activities requiring alertness until they know how the medicine affects them. Regular medical monitoring may be required during treatment. The medication should not be discontinued abruptly without consulting a healthcare professional, as this may affect treatment outcomes.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children. Do not use after the expiry date or if the packaging is damaged, opened, or shows signs of tampering.